Free Trial

Sonnet BioTherapeutics (SONN) SEC Filings & 10K Form

$0.86
+0.01 (+1.18%)
(As of 07/26/2024 ET)

Recent Sonnet BioTherapeutics SEC Filings

DateFilerForm TypeView
07/24/2024
7:36 AM
Sonnet BioTherapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/15/2024
11:15 PM
Sonnet BioTherapeutics (Filer)
Form EFFECT
07/15/2024
4:05 PM
Sonnet BioTherapeutics (Filer)
Form 424B3
07/05/2024
3:06 PM
Sonnet BioTherapeutics (Filer)
Form S-3
Registration statement under Securities Act of 1933  
06/20/2024
3:49 PM
Sonnet BioTherapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/13/2024
7:15 AM
Sonnet BioTherapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/22/2024
6:35 AM
Sonnet BioTherapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/20/2024
8:25 AM
Sonnet BioTherapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/16/2024
11:15 PM
Sonnet BioTherapeutics (Filer)
Form EFFECT
05/14/2024
4:25 PM
Sonnet BioTherapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/03/2024
7:30 AM
Sonnet BioTherapeutics (Filer)
Form S-1
Registration statement under Securities Act of 1933  
05/03/2024
7:00 AM
Sonnet BioTherapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/11/2024
6:30 AM
Sonnet BioTherapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/06/2024
3:20 PM
Sonnet BioTherapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/14/2024
6:35 AM
Sonnet BioTherapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/14/2024
6:30 AM
Sonnet BioTherapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
01/04/2024
11:15 PM
Sonnet BioTherapeutics (Filer)
Form EFFECT
12/27/2023
3:56 PM
Sonnet BioTherapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/22/2023
3:31 PM
Sonnet BioTherapeutics (Filer)
Form S-3
Registration statement under Securities Act of 1933  
12/15/2023
3:30 PM
Sonnet BioTherapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/17/2023
10:32 AM
Markey John (Filed by)
Sonnet BioTherapeutics (Subject)
Form SC 13G/A
11/06/2023
10:35 AM
Markey John (Filed by)
Sonnet BioTherapeutics (Subject)
Form SC 13G/A
10/27/2023
7:00 PM
Mohan Pankaj (Reporting)
Sonnet BioTherapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/27/2023
7:00 PM
Rao Raghu (Reporting)
Sonnet BioTherapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/26/2023
8:00 AM
Sonnet BioTherapeutics (Filer)
Form 424B4
10/24/2023
11:16 PM
Sonnet BioTherapeutics (Filer)
Form EFFECT
10/19/2023
4:14 PM
Sonnet BioTherapeutics (Filer)
Form S-1/A
10/04/2023
3:18 PM
Sonnet BioTherapeutics (Filer)
Form S-1/A
09/28/2023
7:48 AM
Sonnet BioTherapeutics (Filer)
Form S-1/A
09/19/2023
3:30 PM
Sonnet BioTherapeutics (Filer)
Form S-1
Registration statement under Securities Act of 1933  
09/19/2023
7:30 AM
Sonnet BioTherapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/07/2023
10:01 AM
Markey John (Reporting)
Sonnet BioTherapeutics (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
09/01/2023
7:30 AM
Sonnet BioTherapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/31/2023
4:18 PM
Sonnet BioTherapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/22/2023
7:30 AM
Sonnet BioTherapeutics (Filer)
Form DEFA14A
08/22/2023
7:30 AM
Sonnet BioTherapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/21/2023
3:31 PM
Sonnet BioTherapeutics (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
08/14/2023
7:20 AM
Sonnet BioTherapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
08/14/2023
7:15 AM
Sonnet BioTherapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/09/2023
11:15 PM
Sonnet BioTherapeutics (Filer)
Form EFFECT
08/07/2023
6:00 AM
Markey John (Filed by)
Sonnet BioTherapeutics (Subject)
Form SC 13G/A
How to build the ultimate dividend portfolio (Ad)

There’s a free dividend workshop that shows how anyone can build the ultimate dividend workshop in 3 basic steps? PLUS: You’ll get the names and tickers of the Best Dividend Stocks for FREE… This way, by the time you finish the workshop you’ll be fully equipped with the knowledge to start unlocking dividend checks for yourself… Over and over again.

Click here and I’ll show you how to build the ultimate dividend portfolio.
(Data available from 1/1/2016 forward)


Related Companies and Tools

This page (NASDAQ:SONN) was last updated on 7/27/2024 by MarketBeat.com Staff

From Our Partners